Abstract:OBJECTIVE:To explore the synergistic effects on proliferation and apoptosis by targeted suppression of epidermal growth factor receptor (EGFR) in combination with blockade of Hedgehog signaling pathways in pancreatic cancer cells and examine the synergistic mechanism of Hedgehog and EGFR signaling pathways.METHODS:The sequences of RNA interference targeting EGFR gene were designed, synthesized and cloned into the pFU-GW-RNAi vector. And a stable transfection cell line was obtained by transfecting the human Panc-1 cells with lentivirus. The expressions of Shh and Gli1 were tested by real-time polymerase chain reaction (PCR). The antiproliferative effect was examined by the assays of colony formation and methyl thiazolyl tetrazolium (MTT). Fluorescence activated cell sorter (FACS) was applied to assay the apoptotic rate in all experimental groups. Western blot was applied to detect the phosphorylation levels of ERK and AKT.In vivo nude mice tumorigenicity model was used to test the effect of growth inhibition.RESULTS:The RNAi technology with lentivirus could restrain the expression of EGFR gene. After the blocking of EGFR and Hedgehog signaling pathways by RNAi silencing, the chemosensitivity to cyclopamine significantly increased in human pancreatic cancer cells. The half-inhibitory concentration (IC 50) of cyclopamine declined from (2.978 ± 0.336) to (1.698 ± 0.057) µmol/L (P < 0.05). The prophase apoptotic rate of co-treated group was as high as 38.75% and it was significantly higher than the RNAi silencing EGFR (17.65%) and control groups (3.02%) (P < 0.05). The results of tumor xenografts assay showed that the tumor volume of co-treated group (394.8 ± 87.5 mm(3)) was significantly lower than that of simple EGFR RNAi (594.7 ± 86.1 mm(3)) and single cyclopamine treated group (771.3 ± 82.9 mm(3)); the combination treatment could also produce obviously synergistic antiproliferative effect in colony formation assays. After RNAi silencing EGFR, the phosphorylation levels of ERK and AKT decreased significantly versus the control group. Further reduction was obtained with the combined use of cyclopamine in the co-treated group.CONCLUSION:The blocking of EGFR and Hedgehog signaling pathways by RNAi silencing may further inhibit cell proliferation and increase apoptosis in vivo and in vitro in human pancreatic cancer cells. The synergism of Hh and EGFR signaling pathways may be correlated with the phosphorylation levels of ERK and AKT.

Deguelin Inhibits Proliferation and Migration of Human Pancreatic Cancer Cells in Vitro Targeting Hedgehog Pathway.

Deguelin Induces Apoptosis in Colorectal Cancer Cells by Activating the P38 MAPK Pathway.

Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway.

Deguelin Exerts Anticancer Activity of Human Gastric Cancer MGC-803 and MKN-45 Cells in Vitro

Deguelin, a Natural Rotenoid, Inhibits Mouse Myeloma Cell Growth in Vitro Via Induction of Apoptosis.

Deguelin Impairs Cell Adhesion, Migration And Invasion Of Human Lung Cancer Cells Through The Nf-Kappa B Signaling Pathways

Study of Proliferation Inhibition and Apoptosis Induction of Deguelin in Human Hepatocellular Cancer Cell Line SMMC-7721

Antitumor Effects of Deguelin on H460 Human Lung Cancer Cells in Vitro and in Vivo: Roles of Apoptotic Cell Death and H460 Tumor Xenografts Model.

Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-[Formula: see text]B Signaling Pathways.

Effects of deguelin on proliferation and apoptosis of gastric cancer cells MKN-45

Deguelin Inhibits the Migration and Invasion of U-2 OS Human Osteosarcoma Cells via the Inhibition of Matrix Metalloproteinase-2/-9 in Vitro

Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.

Deguelin—An Inhibitor to Tumor Lymphangiogenesis and Lymphatic Metastasis by Downregulation of Vascular Endothelial Cell Growth Factor‐d in Lung Tumor Model

Studies on the Mechanism of Deguelin-induced Apoptosis of Human Prostate Cancer Cell Lines

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

Deguelin Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting HGF-c-Met Pathway

Deguelin Induces The Apoptosis Of Lung Squamous Cell Carcinoma Cells Through Regulating The Expression Of Galectin-1

Synthesis of pyridyl pyrimidine hedgehog signaling pathway inhibitors and their antitumor activity in human pancreatic cancer

Effects and Mechanisms of Combined Suppression of Epidermal Growth Factor Receptor and Hedgehog Signaling on Proliferation in Pancreatic Cancer Cells

Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway

Deguelin Blocks Cells Survival Signal Pathways and Induces Apoptosis of Hl-60 Cells in Vitro